Profile
BIAFW DHR-PB TMO DHR IDXX A
Company Name bioAffinity Technologies, Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $5.59M $916.76B $184.93B $151.04B $51.27B $33.86B
Employees 0.06K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Maria Zannes Rainer M. Blair Marc N. Casper Rainer M. Blair Jonathan J. Mazelsky Padraig McDonnell
Ratings
BIAFW DHR-PB TMO DHR IDXX A
Quant Rating Score 2 5 3 3 3 4
Quant Rating Sell Strong Buy Neutral Neutral Neutral Buy
Trading
BIAFW DHR-PB TMO DHR IDXX A
Last Close $0.0701 $1261.26 $489.74 $205.29 $647.03 $124.96
High 52 $2 $1261.26 $624.21 $278.02 $682.78 $152.6
Low 52 $0.06 $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High -96.5 % 0 % -21.54 % -26.16 % -5.24 % -18.11 %
Price vs. 52 Week Low 16.83 % 0 % 25.51 % 17.55 % 79.21 % 25.85 %
Total Return
BIAFW DHR-PB TMO DHR IDXX A
1 Month Return -61.06 % 0 % 1.56 % -0.75 % 12.91 % 4.27 %
3 Month Return -63.92 % 0 % 21.3 % 7.78 % 25.5 % 10.31 %
6 Month Return -82.69 % 0 % -7.41 % -1.19 % 48.02 % -2.31 %
9 Month Return -90.26 % 0 % -7.53 % -14.35 % 53.42 % -9.43 %
YTD Return -79.36 % 0 % -5.86 % -10.57 % 56.5 % -6.98 %
1 Year Return -94.11 % 0 % -19.94 % -23.12 % 32.78 % -12.33 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BIAFW DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.58 % 0.33 % 0.56 % - 0.82 %
Dividend Paid and Capex Coverage Ration (TTM) -104.25 % 2.91 % 3.76 % 2.91 % 6.89 % 2.36 %
Dividend Per Share (TTM) - 1.18 % 1.64 % 1.18 % - 0.98 %
Payout Ratio (TTM) - 23.85 % 9.26 % 23.85 % - 23.76 %
Growth
BIAFW DHR-PB TMO DHR IDXX A
Asset Growth -20.77 % -8.22 % -1.42 % -8.22 % 1.03 % 10.06 %
Gross Profit Growth 326.79 % 1.23 % 3.44 % 1.23 % 8.63 % 2.02 %
Revenue Growth 269.68 % -0.06 % 0.05 % -0.06 % 6.46 % -4.73 %
Revenue 3 Year - -20.76 % 12.79 % -20.76 % 25.23 % -1.99 %
Revenue 5 Year - 30.38 % 75.79 % 30.38 % 69.09 % 29.92 %
Revenue 10 Year - 15.17 % 164.64 % 15.17 % 218.38 % 85.12 %
EBIT Growth -13.41 % -7.62 % 13.28 % -7.62 % 3.47 % 12.76 %
Net Income Growth -13.89 % -18.16 % 5.67 % -18.16 % 5.07 % 3.95 %
Net Income 3 Yeari Growth Per Share 13.09 % -40.75 % -15.42 % -40.75 % 23.15 % 5.98 %
Net Income 5 Yeari Growth Per Share -66.23 % 26.78 % 79.48 % 26.78 % 116.76 % 91.02 %
Net Income 10 Yeari Growth Per Share -66.23 % 44.14 % 248.59 % 44.14 % 492.42 % 269.11 %
Operating Income Growth -12.29 % -6.52 % 6.97 % -6.52 % 2.84 % 10.22 %
Operating Cash Flow Growth (CFG) -20.32 % -6.64 % 3.1 % -6.64 % 2.48 % -1.19 %
Operating 3 Year CFG -115.65 % -21.78 % -6.33 % -21.78 % 27.03 % 37.6 %
Operating 5 Year CFG -77.44 % 65.54 % 82.49 % 65.54 % 111.28 % 102.58 %
Operating 10 Year CFG -77.44 % 70.94 % 244.88 % 70.94 % 378.1 % 309.5 %
EPS Growth 19.78 % -17.24 % 6.76 % -17.24 % 5.9 % 5.21 %
EPS Diluted Growth 19.78 % -17.08 % 6.99 % -17.08 % 6.06 % 5.73 %
Book Value Per Share -61.35 % -6.67 % 7.15 % -6.67 % 8.24 % 2.3 %
Share Holder 3 Year Equity Growth Per Share 110.02 % 7.23 % 25.29 % 7.23 % 138.87 % 14.63 %
Share Holder 5 Year Equity Growth Per Share 139.22 % 60.08 % 74.85 % 60.08 % 838.67 % 28.96 %
Share Holder 10 Year Equity Growth Per Share 139.22 % 103.57 % 151.37 % 103.57 % 1547.69 % 63 %
Dividend Per Share Growth - -5.75 % 12.64 % -5.75 % - 4.82 %
Dividend 3 Year Growth Per Share - 1.18 % 52.23 % 1.18 % - 13 %
Dividend 5 Year Growth Per Share - 42.62 % 105.55 % 42.62 % - 31.51 %
Dividend 10 Year Growth Per Share - 224 % 158.83 % 224 % - 136.56 %
Debt Growth -4.91 % -18.07 % -10.43 % -18.07 % -7.53 % 23.28 %
Free Cash Flow Growth -21.17 % -8.39 % 4.91 % -8.39 % 3.26 % -6.85 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Oct 2024
Profitability
BIAFW DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 29.87 % 61.52 % 39.58 % 61.52 % 61.54 % 53.35 %
Return on Assets TTM -246.02 % 4.18 % 6.5 % 4.18 % 29.59 % 9.59 %
Return on Equity TTM -930.2 % 6.69 % 13.27 % 6.69 % 64.42 % 19.46 %
Return on Capital Employed TTM -465.31 % 6.93 % 8.97 % 6.93 % 59.57 % 13.97 %
Net Income Per EBT TTM 100.34 % 83.73 % 93.8 % 83.73 % 80.28 % 85.05 %
EBT Per Ebit TTM 115.75 % 78.61 % 88.39 % 78.61 % 97.81 % 96.75 %
EBIT Per Revenue TTM -131.01 % 21.59 % 18.38 % 21.59 % 31.09 % 21.38 %
Cash Flow To Debt Ratio TTM -1145.58 % 33.25 % 21.51 % 33.25 % 73.21 % 45.35 %
Receivables Turnover TTM 18.21 5.32 4.31 5.32 6.09 4.85
Payables Turnover TTM 4.6 5.36 8.76 5.36 13.32 5.98
Inventory Turnover TTM 122.5 3.44 4.7 3.44 3.96 3.12
Fixed Asset Turnover TTM 835.87 % 374.68 % 448.49 % 374.68 % 464.4 % 346.65 %
Asset Turnover TTM 161.68 % 29.42 % 42.69 % 29.42 % 121.22 % 54.52 %
Operating Cash Flow Per Share TTM -0.32 8.61 20.05 8.61 11.26 5.56
Free Cash Flow Per Share TTM -0.32 6.79 16.32 6.79 9.63 4.17
Cash Per Share TTM 3.34 % 412.7 % 1690.48 % 412.7 % 204.69 % 521.4 %
Operating Cash Flow Sales Ratio TTM -99.92 % 25.69 % 17.54 % 25.69 % 22.43 % 23.91 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.96 % 78.81 % 81.42 % 78.81 % 85.49 % 75.02 %
Cash Flow Coverage Ratios TTM -1145.58 % 33.25 % 21.51 % 33.25 % 73.21 % 45.35 %
Price To Free Cash Flows Ratio TTM -0.9 30.19 29.97 31.06 66.21 28.48
Price To Operating Cash Flows Ratio TTM -0.77 23.81 24.43 24.5 56.89 21.43
Price Cash Flow Ratio TTM -0.77 23.81 24.43 24.5 56.89 21.43
Income Statement (TTM)
BIAFW DHR-PB TMO DHR IDXX A
Revenue $0.01B $23.88B $42.88B $23.88B $3.9B $6.51B
Gross Profit $0B $14.21B $17.73B $14.21B $2.38B $3.54B
Gross Profit Ratio 36.09% 59.5% 41.34% 59.5% 61.04% 54.3%
EBITDA $-0.01B $7.28B $11.8B $7.28B $1.28B $1.87B
Net Income $-0.01B $3.9B $6.34B $3.9B $0.89B $1.29B
EPS Diluted -0.75 5.29 16.53 5.29 10.67 4.43
Balance Sheet (MRQ)
BIAFW DHR-PB TMO DHR IDXX A
Long Term Debt $0B $16.47B $30.3B $16.47B $0.55B $3.49B
Total Liabilities $0B $27.99B $47.65B $27.99B $1.7B $5.95B
Total Equity $0B $49.55B $49.67B $49.55B $1.6B $5.9B
Total Investments $0B $1.82B $2.12B $1.82B $0.06B $0.18B
Total Debt $0B $17.15B $32.78B $17.15B $0.99B $3.57B
Total Assets $0.01B $77.54B $97.32B $77.54B $3.29B $11.85B
Cash Flow Statement (TTM)
BIAFW DHR-PB TMO DHR IDXX A
Net Income $-0.01B $3.9B $6.34B $3.9B $0.89B $1.29B
Inventory $0B $0.15B $-0.03B $0.15B $-0.03B $0.03B
Dividends Paid $0B $-0.77B $-0.58B $-0.77B $0B $-0.27B
Operating Cash Flow $-0.01B $6.69B $8.67B $6.69B $0.93B $1.75B
Capital Expenditure $-0B $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 125.74
ACRS Aclaris Therapeutics, Inc. 1.925
ADVB Advanced Biomed Inc. Common Stock 0.4432
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 3.22
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 0.4294
BIAF bioAffinity Technologies, Inc. 0.2472
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 3.77
BNGOW BioNano Genomics, Inc. WT EXP 082123 0.0036
BNR Burning Rock Biotech Limited 8.69
CDNA CareDx, Inc 13.66
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.7605
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 163.35
CSTL Castle Biosciences, Inc. 24.03
DGX Quest Diagnostics Incorporated 181.69
Unlock